Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Bentink

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Oncotarget|January 9, 2013
SOCS1 mutation subtypes predict divergent outcomes in diffuse large B-Cell lymphoma (DLBCL) patientsBirgit Schif, Jochen K Lennerz, Christian W Kohler, et al.
Lung|September 6, 2024
Utility of the 52-Gene Risk Score to Identify Patients with Idiopathic Pulmonary Fibrosis at Greater Risk of Mortality in the Era of Antifibrotic TherapyJulia F Söllner, Stefan Bentink, Christian Hesslinger, et al.
JAMA Oncology|April 1, 2016
A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial BiopsyJames McKiernan, Michael J Donovan, Vince O'Neill, et al.
Plos One|February 21, 2012
Angiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancerStefan Bentink, Benjamin Haibe-Kains, Thomas Risch, et al.
Plos One|December 5, 2013
Gene expression signature of normal cell-of-origin predicts ovarian tumor outcomesMelissa A Merritt, Stefan Bentink, Matthew Schwede, et al.
Haematologica|March 28, 2008
Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphomaJudith Dierlamm, Eva M Murga Penas, Stefan Bentink, et al.
Blood|May 30, 2008
Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trialsWolfram Klapper, Monika Szczepanowski, Birgit Burkhardt, et al.
Plos One|January 7, 2011
Therapeutic implications of GIPC1 silencing in cancerThomas W Chittenden, Jane Pak, Renee Rubio, et al.
Genes, Chromosomes & Cancer|October 2, 2008
Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression statusCarsten Schwaenen, Andreas Viardot, Hilmar Berger, et al.
The New England Journal of Medicine|June 9, 2006
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profilingMichael Hummel, Stefan Bentink, Hilmar Berger, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Oncotarget|January 9, 2013
SOCS1 mutation subtypes predict divergent outcomes in diffuse large B-Cell lymphoma (DLBCL) patientsBirgit Schif, Jochen K Lennerz, Christian W Kohler, et al.
Lung|September 6, 2024
Utility of the 52-Gene Risk Score to Identify Patients with Idiopathic Pulmonary Fibrosis at Greater Risk of Mortality in the Era of Antifibrotic TherapyJulia F Söllner, Stefan Bentink, Christian Hesslinger, et al.
JAMA Oncology|April 1, 2016
A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial BiopsyJames McKiernan, Michael J Donovan, Vince O'Neill, et al.
Plos One|February 21, 2012
Angiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancerStefan Bentink, Benjamin Haibe-Kains, Thomas Risch, et al.
Plos One|December 5, 2013
Gene expression signature of normal cell-of-origin predicts ovarian tumor outcomesMelissa A Merritt, Stefan Bentink, Matthew Schwede, et al.
Haematologica|March 28, 2008
Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphomaJudith Dierlamm, Eva M Murga Penas, Stefan Bentink, et al.
Blood|May 30, 2008
Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trialsWolfram Klapper, Monika Szczepanowski, Birgit Burkhardt, et al.
Plos One|January 7, 2011
Therapeutic implications of GIPC1 silencing in cancerThomas W Chittenden, Jane Pak, Renee Rubio, et al.
Genes, Chromosomes & Cancer|October 2, 2008
Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression statusCarsten Schwaenen, Andreas Viardot, Hilmar Berger, et al.
The New England Journal of Medicine|June 9, 2006
A biologic definition of Burkitt's lymphoma from transcriptional and genomic profilingMichael Hummel, Stefan Bentink, Hilmar Berger, et al.
Pageof 3